» Authors » N A Kernan

N A Kernan

Explore the profile of N A Kernan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 1613
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatt V, Shune L, Lauer E, Lubin M, Devlin S, Scaradavou A, et al.
Bone Marrow Transplant . 2016 Sep; 51(12):1579-1583. PMID: 27643868
Autoimmune hemolysis (AH) and immune thrombocytopenic purpura (ITP) are recognized complications after cord blood transplantation (CBT). We evaluated the incidence and characteristics of AH/ITP after double-unit CBT in a day...
2.
Anur P, Friedman D, Sklar C, Oeffinger K, Castiel M, Kearney J, et al.
Bone Marrow Transplant . 2016 Mar; 51(7):938-44. PMID: 26999465
Hematopoietic stem cell transplantation (HSCT) is curative for hematological manifestations of Fanconi anemia (FA). We performed a retrospective analysis of 22 patients with FA and aplastic anemia, myelodysplastic syndrome or...
3.
Dahi P, Ponce D, Devlin S, Evans K, Lubin M, Gonzales A, et al.
Bone Marrow Transplant . 2014 Jul; 49(9):1184-6. PMID: 25000459
The feasibility of selecting cord blood (CB) units at high-resolution HLA match has not been investigated. We analyzed the high-resolution donor-recipient HLA match of 100 double-unit 4-6/6 HLA-A,-B antigen, -DRB1...
4.
Ponce D, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S, Goldberg J, et al.
Biol Blood Marrow Transplant . 2013 Feb; 19(6):904-11. PMID: 23416854
Manifestations of and risk factors for graft-versus-host disease (GVHD) after double-unit cord blood transplantation (DCBT) are not firmly established. We evaluated 115 DCBT recipients (median age, 37 years) who underwent...
5.
Avery S, Voss M, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S, et al.
Bone Marrow Transplant . 2011 Dec; 47(8):1056-60. PMID: 22139066
Delayed or failed engraftment remains a concern after cord blood transplantation (CBT) even when using double-unit grafts. Therefore, we analyzed the association between BM assessment performed approximately 21 days after...
6.
Tarek N, Kernan N, Prockop S, Scaradavou A, Small T, OReilly R, et al.
Bone Marrow Transplant . 2011 Jul; 47(5):744-6. PMID: 21785471
No abstract available.
7.
Perales M, Jenq R, Goldberg J, Wilton A, Lee S, Castro-Malaspina H, et al.
Bone Marrow Transplant . 2010 Jan; 45(9):1408-16. PMID: 20062091
T-cell depleted allogeneic hematopoietic SCT (TCD-HSCT) have shown durable disease-free survival with a low risk of GVHD in patients with AML. We investigated this approach in 61 patients with primary...
8.
Keever-Taylor C, Wagner J, Kernan N, Small T, Carter S, Thompson J, et al.
Bone Marrow Transplant . 2009 Jul; 45(3):587-9. PMID: 19617904
No abstract available.
9.
Perales M, Ishill N, Lomazow W, Weinstock D, Papadopoulos E, Dastigir H, et al.
Bone Marrow Transplant . 2007 Jul; 40(5):481-6. PMID: 17618322
Daclizumab has been shown to have activity in acute GVHD, but appears to be associated with an increased risk of infection. To investigate further the long-term effects of daclizumab, we...
10.
Kamboj M, Mihu C, Sepkowitz K, Kernan N, Papanicolaou G
Transpl Infect Dis . 2007 May; 9(4):265-9. PMID: 17511822
Background: Diarrhea is a common complication of allogeneic bone marrow transplantation. Microbiologic stool studies are frequently ordered to rule out infectious etiology. The utility of examining multiple stool specimens per...